Φορτώνει......
Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
BACKGROUND: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit in the treatment of virus-associated diseases. For this purpose, we screened for inhibitory compounds...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Biomed Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217310/ https://ncbi.nlm.nih.gov/pubmed/28056971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0313-9 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|